TechnoPhage is currently looking for a Junior Clinical Trial Manager to join our clinical research team. The candidate should have an academic...
TechnoPhage announces completion of innovative clinical trial with bacteriophage cocktail indicated for the treatment of diabetic foot infections
TechnoPhage is proud to announce that the Phase I/IIa Clinical Trial of TP-102, a novel bacteriophage cocktail developed for the treatment of...
TechnoPhage announced that it has provided TP-102, developed for the treatment of infected diabetic foot ulcers, for two compassionate use cases,...
Invest in our products
Learn more about GMP manufacturing
Who we are, What we do
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology